September 17th, 2010
Podcast 101: Osteoarthritis, chondroitin, and glucosamine — one of these things doesn’t belong.
Podcast: Play in new window | Download
Subscribe: RSS
Answer: Osteoarthritis. Two are nostrums and the other is a disease, but the nostrums have no appreciable effect — on osteoarthritis at least. We discuss a BMJ meta-analysis that uses novel methods to prove the point.
The good news is that neither chondroitin nor glucosamine is dangerous, but the bad news is that we spend so much hoping that this is the right combination to alleviate arthritic pain.
Interview related link:
News-related links:
- PSA screening overdiagnoses prostate cancer and doesn’t lower mortality
- A distinct phenotype of chronic obstructive pulmonary disease
- New resistance factor, NDM-1, shows up in North America
Categories: Audio, Chondroitin, glucosamine, Osteoarthritis, pain, Uncategorized
Tags: antibiotic resistance, Chondroitin, chronic obstructive pulmonary disease, COPD, glucosamine, meta-analysis, NDM-1, Osteoarthritis, pain, Peter Juni, prostate screening, PSA, Sven Trelle
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Most Commented
- Podcast 256 — Anthony Fauci: Talking with patients about COVID-19 (27)
- Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes (8)
- Podcast 251: Intermittent fasting (7)
- Podcast 214: Drug-drug interactions and bleeding risks with NOACs (6)
- Podcast 261: COVID-19 as a medical disaster (6)
Subscribe to Clinical Conversations via Email
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin